Skip to main content

Blickensdoerfer Hans-Martin's Form 4 filing

Staar Surgical Co (STAA) · filed Sep 9, 2021

Accession no.
0001209191-21-055273
Filed
Sep 9, 2021
Trade date
Sep 7, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $6.40M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Blickensdoerfer Hans-MartinCIK 0001488891Officer (Sr. VP, Comm. Ops, China)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 7, 2021Common StockSSaleDisposed−11,522$157.40F1−$1,813,562.877,200Direct
Sep 7, 2021Common StockMOption exerciseAcquired+14,031$35.98+$504,835.3891,231Direct
Sep 7, 2021Common StockMOption exerciseAcquired+15,100$27.53+$415,703106,331Direct
Sep 7, 2021Common StockSSaleDisposed−29,131$157.40F2−$4,585,219.477,200Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 7, 2021Common StockMOption exerciseDisposed−14,031$0.00$04,109Direct
Sep 7, 2021Common StockMOption exerciseDisposed−15,100$0.00$016,879Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.40 to $157.45, inclusive.

Referenced by the price of 1 transaction in Table I.

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.40 to $157.46, inclusive.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)